In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 70 for your search:
Trial Status:  Active
Lead Organization/Cooperative Group:  COG
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: ANHL1131, NCI-2012-01963, CDR0000732604, U10CA098543, COG-ANHL1131, NCT01595048

2.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 3 to 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: ACNS0331, COG-ACNS0331, CDR0000365506, NCT00085735

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 3
Sponsor: NCI, Other
Protocol IDs: ACNS0334, NCI-2009-00338, COG-ACNS0334, CDR0000483683, U10CA098543, NCT00336024

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 10 and under
Sponsor: NCI, Other
Protocol IDs: ARET0321, NCI-2009-00421, COG-ARET0321, CDR0000573987, U10CA098543, NCT00554788

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and under at diagnosis
Sponsor: NCI, Other
Protocol IDs: AALL0631, NCI-2009-00313, COG-AALL0631, CDR0000573996, U10CA098543, NCT00557193

6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: Under 30 at initial diagnosis
Sponsor: NCI, Other
Protocol IDs: AREN0534, NCI-2011-01953, CDR0000649716, U10CA098543, COG-AREN0534, NCT00945009

7.

Phase: Phase III
Type: Tissue collection/Repository, Treatment
Status: Active
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: AHEP0731, NCI-2011-01975, CDR0000654889, COG-AHEP0731, U10CA098543, NCT00980460

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS0831, NCI-2011-02029, COG-ACNS0831, CDR0000668560, U10CA098543, NCT01096368

9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 1 to < 10
Sponsor: NCI, Other
Protocol IDs: AALL0932, NCI-2011-02599, CDR0000683227, U10CA098543, COG-AALL0932, NCT01190930

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: AEWS1031, NCI-2011-02611, COG-AEWS1031, CDR0000687639, U10CA098543, NCT01231906

11.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 6 months to 21 years
Sponsor: NCI, Other
Protocol IDs: ACCL0934, NCI-2011-02636, CDR0000695661, COG-ACCL0934, U10CA095861, NCT01371656

12.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 4 to 21
Sponsor: NCI, Other
Protocol IDs: ACCL1031, NCI-2011-02635, CDR0000695718, COG-ACCL1031, U10CA095861, NCT01305200

13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 3 months to 30 years
Sponsor: NCI, Other
Protocol IDs: ACCL0933, NCI-2011-02640, CDR0000695748, COG-ACCL0933, U10CA095861, NCT01307579

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: AALL1131, NCI-2011-03797, CDR0000706370, U10CA098543, COG-AALL1131, NCT01406756

15.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 3 months to 20 years
Sponsor: NCI, Other
Protocol IDs: ACCL1131, NCI-2012-00102, CDR0000721415, COG-ACCL1131, U10CA095861, NCT01503515

16.

Phase: Phase III
Type: Educational/Counseling/Training, Treatment
Status: Active
Age: 12 to 25
Sponsor: NCI
Protocol IDs: COG-ACCL1033, ACCL1033, NCT01503632

17.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 2 months to 21 years
Sponsor: NCI, Other
Protocol IDs: ACCL1034, NCI-2013-00595, U10CA095861, COG-ACCL1034, NCT01817075

18.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL0912, COG-ADVL0912, CDR0000647587, NCT00939770

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 month to 30 years
Sponsor: NCI, Other
Protocol IDs: AAML05P1, COG-AAML05P1, CDR0000572744, NCT00553202

20.

Phase: Phase II
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 11 to 24
Sponsor: NCI, Other
Protocol IDs: ANUR1131, NCI-2012-00682, COG-ANUR1131, CDR0000726664, U10CA095861, R01CA162181, NCT01556256

21.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 3 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS1123, NCI-2012-01967, CDR0000734032, U10CA098543, COG-ACNS1123, NCT01602666

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 3 to 18
Sponsor: NCI, Other
Protocol IDs: ASCT1221, NCI-2013-00738, U10CA098543, COG-ASCT1221, NCT01824693

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 47 months old or younger
Sponsor: NCI, Other
Protocol IDs: ACNS1221, NCI-2013-02379, COG-ACNS1221, U10CA098543, NCT02017964

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL1011, COG-ADVL1011, NCT01164163

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 13 months to 21 years
Sponsor: NCI, Other
Protocol IDs: ADVL1212, NCI-2012-01968, U01CA097452, COG-ADVL1212, NCT01606878
1    
New Search